Aurinia Pharmaceuticals Inc (AUPH)

Feb 21, 2025

(AUPH) On The My Stocks Page - Stock Traders Daily

Feb 21, 2025

Feb 21, 2025

Aurinia Pharmaceuticals: There's Still Time For Sales Growth (NASDAQ:AUPH) - Seeking Alpha

Feb 21, 2025

Feb 20, 2025

Aurinia Pharmaceuticals (AUPH) to Release Earnings on Thursday - MarketBeat

Feb 20, 2025

Feb 20, 2025

When Will Aurinia Report Q4 Earnings? Key Date and Details for Investors - StockTitan

Feb 20, 2025

Feb 19, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Rating Lowered to Buy at StockNews.com - MarketBeat

Feb 19, 2025

Feb 19, 2025

retail investors who own 52% along with institutions invested in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) saw increase in their holdings value last week - Simply Wall St

Feb 19, 2025

Feb 19, 2025

Compagnie Lombard Odier SCmA Cuts Stock Holdings in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - MarketBeat

Feb 19, 2025

Feb 19, 2025

Short Interest in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Grows By 25.5% - MarketBeat

Feb 19, 2025

Feb 18, 2025

Aurinia (AUPH) Upgraded to Buy: Here's Why - MSN

Feb 18, 2025

Feb 18, 2025

Head-To-Head Analysis: Aurinia Pharmaceuticals (NASDAQ:AUPH) vs. XBiotech (NASDAQ:XBIT) - Defense World

Feb 18, 2025

Feb 16, 2025

Aurinia Pharmaceuticals (AUPH) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Feb 16, 2025

Feb 14, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Downgraded by StockNews.com to Buy - MarketBeat

Feb 14, 2025

Feb 13, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Share Price Crosses Below 50 Day Moving AverageWhat's Next? - MarketBeat

Feb 13, 2025

Feb 13, 2025

Aurinia Pharmaceuticals (AUPH) to Release Quarterly Earnings on Thursday - Defense World

Feb 13, 2025

Feb 11, 2025

Perhaps timely catching Aurinia Pharmaceuticals Inc (AUPH) would be a good idea - SETE News

Feb 11, 2025

Feb 11, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Lowered to Buy Rating by StockNews.com - Defense World

Feb 11, 2025

Feb 11, 2025

Objective long/short (AUPH) Report - Stock Traders Daily

Feb 11, 2025

Feb 10, 2025

A Guide To The Risks Of Investing In Aurinia Pharmaceuticals Inc (AUPH) - Knox Daily

Feb 10, 2025

Feb 07, 2025

Aurinia Pharmaceuticals Inc (AUPH) Stock: A SWOT Analysis - The News Heater

Feb 07, 2025

Feb 07, 2025

Layoff Tracker: Viracta, X4 and BMS Detail Current, Upcoming Cuts - BioSpace

Feb 07, 2025

Feb 06, 2025

You might want to take a look at Aurinia Pharmaceuticals Inc (AUPH) now - SETE News

Feb 06, 2025

Feb 04, 2025

Aurinia Pharmaceuticals Inc [AUPH] Investment Guide: What You Need to Know - Knox Daily

Feb 04, 2025

Feb 04, 2025

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Short Interest Up 29.2% in January - MarketBeat

Feb 04, 2025

Feb 01, 2025

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Position Cut by SG Americas Securities LLC - MarketBeat

Feb 01, 2025

Feb 01, 2025

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Shares Sold by SG Americas Securities LLC - Defense World

Feb 01, 2025

Jan 29, 2025

Possible Bearish Signals With Aurinia Pharmaceuticals Insiders Disposing Stock - Simply Wall St

Jan 29, 2025

Jan 19, 2025

(AUPH) Investment Analysis - news.stocktradersdaily.com

Jan 19, 2025

Jan 19, 2025

Aurinia slashes workforce by 45% to focus on lupus and autoimmune assets - MSN

Jan 19, 2025

Jan 16, 2025

Aurinia: My 2024 Sell Call Was WrongSo I'm Upgrading To 'Hold' In 2025 (NASDAQ:AUPH) - Seeking Alpha

Jan 16, 2025

Jan 15, 2025

Nephrotic Syndrome Market Set to Grow Substantially Through 2034, DelveInsight Projects | GlaxoSmithKline, Goldfinch Bio, Inc., Travere Therapeutics, Inc., Aurinia Pharmaceuticals, Bristol-Myers Squib - The Globe and Mail

Jan 15, 2025

Jan 15, 2025

Amid Sagging Market, I'm Picking Up These 3 Biotech Stocks - TheStreet

Jan 15, 2025

Jan 14, 2025

Is Aurinia Pharmaceuticals Poised for Growth in the Biotech Space? - Inkl

Jan 14, 2025

Jan 14, 2025

AUPH: Is Aurinia Pharmaceuticals Poised for Growth in the Biotech Space? - StockNews.com

Jan 14, 2025

Jan 13, 2025

Aurinia Pharmaceuticals Becomes Oversold (AUPH) - Nasdaq

Jan 13, 2025

Jan 12, 2025

Barclays PLC Boosts Holdings in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - MarketBeat

Jan 12, 2025

Jan 11, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Rating Upgraded by StockNews.com - Defense World

Jan 11, 2025

Jan 09, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Upgraded by StockNews.com to Strong-Buy Rating - MarketBeat

Jan 09, 2025

Jan 09, 2025

Long Term Trading Analysis for (AUPH) - Stock Traders Daily

Jan 09, 2025

Jan 08, 2025

New American College of Rheumatology Guidelines for Lupus Nephritis Recommend Triple Therapy, Highlighting a Shift in Current Treatment Practices, According to Spherix Global Insights - GlobeNewswire Inc.

Jan 08, 2025

Jan 03, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH shareholders incur further losses as stock declines 5.2% this week, taking five-year losses to 57% - Simply Wall St

Jan 03, 2025

Jan 03, 2025

Franklin Resources Inc. Sells 75,024 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - MarketBeat

Jan 03, 2025

Dec 28, 2024

Barclays PLC Acquires 143,072 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - MarketBeat

Dec 28, 2024

Dec 24, 2024

Aurinia Pharmaceuticals laying off dozens in Montgomery County - The Business Journals

Dec 24, 2024

Dec 24, 2024

State Street Corp Has $21.59 Million Stake in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - MarketBeat

Dec 24, 2024